deliv better-than-anticip fiscal result revenu
million million consensu expect led rel
strength healthcar equip flat organ growth despit comp
fiscal life scienc organ addit favor
discret item contribut lower-than-expect adjust tax rate
quarter strength two area help off-set lower adjust
oper margin perform anticip currenc chang
weigh adjust gross margin bp headwind increas
expens step-up hire within instrument repair busi support
futur growth higher corpor expens primarili bonus impact
adjust oper expens total compani fiscal adjust ep
exceed estim consensu expect
low-to-mid-single-digit improv healthcar equip busi
neg organ growth segment million
increment sale outsourc steril process initi start
fiscal northwel sever addit custom ramp
million time slightli slower organ growth rel
level life scienc overal healthcar specialti servic
divis given ste strong equip backlog posit year-over-
year enter new product launch activ believ
compani conserv organ growth guidanc earli year
think reason note better healthcar equip
perform increment outsourc steril process sale alon
add bp organ growth
anticip adjust ep versu prior consensu
expect compani assum adjust oper margin
expans typic bp rang despit expect
million expens headwind relat start-up expens outsourc
million contribut adjust oper incom currenc chang
assum forward rate march appear littl optimist given
currenc rate movement month lastli anticip year-
over-year increas free cash flow million aid lower anticip
acquisit integr expens anniversari one-tim bonu
employe outsid senior manag
total debt total asset
lower adjust ep estim primarili
reflect slightli higher adjust oper expens tax rate assumpt
addit initi adjust ep forecast expect
see ste organ growth acceler rang
think contribut modest multipl expans reiter buy
rate increas price target
import pleas read disclosur disclaim page report
report fiscal adjust ep consensu expect estim
quarter lower-than-anticip adjust tax rate drove upsid versu adjust ep
forecast revenu also higher anticip
ste fiscal revenu increas year-over-year million exceed consensu
expect million estim million quarter report constant currenc
organ growth forecast led strength healthcar equip life
scienc note ste report constant currenc organ growth includ impact smaller acquisit
plcfiscal adjust incom statement revenu analysisnorthcoast research thousand except percentag per share gross sg sg oper oper interest expens incom incom tax incom extra margin extra incom com share growth ep growth life appli steril healthcar specialti compani report northcoast research estim factset exclud smaller acquisit compass medic genii apono medic padlock clip defect
closur system estim compani fiscal organ growth rang versu
growth posit fiscal well forecast also exclud compani
acquisit genii apono medic padlock clip defect closur system estim ste healthcar
product organ growth closer well estim
steri plcorgan growth analysi benefit signific year-over-year increas shipment hurt difficult year-over-year comparison shipmentssourc compani report northcoast research plchealthcar product organ growth analysi benefit signific year-over-year increas shipment hurt difficult year-over-year comparison shipmentssourc compani report northcoast research heard posit commentari industri contact equip infect prevent
market regard calendar capit equip sale favor market trend also contribut
better-than-anticip fiscal healthcar equip organ growth total compani post
flattish healthcar equip organ growth despit difficult comp fiscal well
neg forecast healthcar consum servic organ growth year-over-year
respect also remain strong aid part compani celer biolog indic launch quarter
addit fiscal revenu upsid healthcar equip busi also saw strong year-over-
year improv healthcar equip backlog enter specif ste healthcar backlog
year-over-year think reflect improv project activ well better new product
launch activ endo v-pro max roll earli total ste combin order
backlog healthcar life scienc product increas year-over-year million end
fiscal compani lifesci backlog remain except strong year-over-year
fiscal ste life scienc busi post organ growth well estim
expect compani life scienc capit sale year-over-year particularli strong driven
robust order backlog enter quarter contrast life scienc consum servic revenu
declin slightli year-over-year benefit revenu stream creat equip sale
futur quarter
steri plcorder backlog analysi northcoast researchord backlog order scienc order scienc compani report northcoast research estim aid black diamond video acquisit
ste appli steril ast busi achiev organ growth fiscal
similar forecast growth lower recent quarter think primarili reflect tough
comp organ growth fiscal rather new concern busi
ste healthcar specialti servic busi achiev report constant currenc organ growth
fiscal howev compani acquisit compass medic lump report organ growth
exclud estim acquisit contribut believ organ growth closer
similar forecast believ market growth instrument repair track mid-single-
digit rang keep pace market also encourag hear compani discuss
fiscal hire busi ahead new contract win make us feel better outlook
segment
ste fiscal adjust oper margin increas bp year-over-year
estim quarter adjust oper expens similar forecast increas adjust
gross margin bp less anticip state previous currenc chang weigh
adjust gross margin bp headwind increas expens step-up hire within
instrument repair busi support futur growth higher corpor expens primarili bonus impact
adjust oper expens busi segment standpoint adjust oper margin expans
particularli strong healthcar specialti servic bp year-over-year aid divestitur
improv instrument repair appli steril bp year-over-year
currenc chang weigh ste two busi product-rel revenu healthcar
life scienc
expect constant currenc organ growth includ low-to-mid-single-digit improv
healthcar equip busi neg organ growth segment million
increment sale outsourc steril process initi start fiscal northwel
sever addit custom ramp million time slightli slower organ growth rel
level life scienc overal healthcar specialti servic divis given ste strong equip
backlog posit year-over-year enter new product launch activ believ
compani conserv organ growth guidanc earli year think reason
note better healthcar equip perform increment outsourc steril process sale alon
add bp organ growth
anticip adjust ep versu prior consensu expect compani
assum adjust oper margin expans typic bp rang despit expect
million expens headwind relat start-up expens outsourc steril process initi note
ste guidanc also assum million contribut adjust oper incom currenc chang
assum forward rate march appear littl optimist given currenc rate movement
month lastli anticip year-over-year increas free cash flow million aid lower
anticip acquisit integr expens anniversari one-tim bonu employe outsid
senior manag
lower adjust ep estim primarili reflect slightli higher adjust
oper expens tax rate assumpt addit initi adjust ep forecast
expect see ste organ growth acceler rang think
contribut modest multipl expans reiter buy rate increas price target
steri plcannual incom statement analysi adjust northcoast research thousand except percent per share gross gross total oper sg sg oper oper net interest expens interest net expens incom incom incom tax minor net incom extra net margin extra extra net incom continu net wghd com share ep ep revenu growth adjust ep growth compani report northcoast research estim disclosur
